domain | abelsontaylor.com |
summary | The provided content outlines key milestones for Med Ad News Agency since its establishment. The timeline includes:
- Inception in 1981 - Launching its first pharmaceutical drug, Cardene (1989) - Introduction to Ambien and Prevacid (1992 & 1996), with both receiving recognition as the "Med Ad News of the Year" for Hytrin and Biaxin respectively. - Dale Taylor turning down an offer in 1997 - Launching new products such as Actos, Neulasta; a significant rebranding by removing a hyphen between its names (2003); introduction to DTC campaigns with Zimmer Gender Knee and Tarceva.
Further developments include:
- An equity status offering for employees under Dale Taylor's leadership in 2005 - A recognition award won through the CLIO Ad of the Year campaign. - Adoption as an early iPad app industry leader, launching Latuda shortly after Apple's launch (2010). - Continuously introducing new drugs like Incivek and Contrave while being named Agency of the Year by PM360 & MMM in 2016.
Notable events also include:
- Launching its first immune-oncology drug Imfinzi. - A DTC campaign for Coolief initiated amidst a challenging pandemic year (2021). - Transition to new headquarters coinciding with an increased work from home setup due to the global health crisis and meeting revenue goals despite such adversities.
In 2019, Dale Taylor left while Jeff Berg took over as President. In January of 2022, Med Ad News Agency became part of a newly formed AT Group along with its sister agency at Nutrient. |
title | Health & Wellness Advertising Agency in Chicago | AbelsonTaylor, Inc. |
description | Full-service, Chicago agency delivering award-winning design, creative, and marketing strategies for pharmaceutical and consumer health brands. |
keywords | brand, agency, group, success, year, taylor, strategy, first, news, dale, campaign, part, skip, initiative, menu, close, blog |
upstreams |
|
downstreams |
|
nslookup | A 141.193.213.10 |
created | 2025-05-24 |
updated | 2025-06-01 |
summarized | 2025-06-01 |
|
|